Sylwia Huber
Senior Principal Scientist & Biophysics Matrix Lead Roche
Sylwia Huber is Senior Principal Scientist and Biophysics Matrix Lead at Roche, where she oversees biophysical strategy and innovation across lead discovery and beyond. With more than 15 years of expertise in analysing biomolecular interactions, Sylwia has led teams advancing SPR, AUC, fluorescence, and other label-free methods to characterise biomolecular interactions (e.g. proteins, antibodies, nucleic acids, and small molecules). She has a long-standing interest in novel biophysical technologies and their applications to advance drug discovery. At the Summit, Sylwia will discuss leveraging focal molography to measure true-context molecular interactions directly in native biofluids and its complementarity to classical discovery tools.
Seminars
Beyond technical expertise, career progression in biophysics-driven drug discovery and development often depends on visibility, networking, and navigating the evolving landscape between academia, biotech, and pharma. This roundtable creates an open forum for early-career scientists to share experiences, ask questions, and gain insights from senior industry and academic leaders.
- Join a candid, interactive discussion with scientists at different career stages sharing their journeys from the bench to leadership
- Gain practical advice on transitioning between academia, biotech, and pharma, and how to build interdisciplinary expertise across biophysics, chemistry, and computation
- Discover strategies for mentorship, visibility, and professional growth to shape your long-term impact in biophysics and drug discovery.
- Learn how focal molography enables direct measurement of biomolecular interactions with native protein working with complex media such as serum, cell lysates or other biofluids serving as native matrices
- Explore how this method complements classical tools such as SPR, uncovering differences invisible in purified systems
